Atlas Trials

Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma Patients

Clinical trial NCT00722098 · TERMINATED

Trial details

NCT number
NCT00722098
Sponsor
Baylor Research Institute
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Malignant Melanoma Stage IV
Start date
2008-06-01
Primary completion
2011-04-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.